Diagnostic Assay Probe Development
Genetic mutations, pathogens, oncology biomarkers
Research/Pre-clinicalActive
Key Facts
Indication
Genetic mutations, pathogens, oncology biomarkers
Phase
Research/Pre-clinical
Status
Active
Company
About Integen LLC
InteGen LLC is a private, pre-revenue biotechnology firm developing a proprietary platform for next-generation DNA probes. The company's core technology is designed to improve genetic testing and molecular diagnostics by offering superior specificity and the ability to detect multiple targets simultaneously. Operating in the high-growth diagnostics and genomics markets, InteGen's success hinges on translating its innovative platform into validated commercial products and securing strategic partnerships. As a small, early-stage company, it faces significant competition and the ongoing challenge of securing funding to advance its technology.
View full company profile